Adipose Tissue-Derived Stromal Cells Primed in Vitro with Paclitaxel Acquire Anti-Tumor Activity

International Journal of Immunopathology and Pharmacology

Volumn 26, Issue , 2013, Pages 33-41

  Bonomi, A ^a   Cocce V ^a   Cavicchini, L ^a   Sisto, F ^a   Dossena, M ^b   Balzarini, P ^c   Portolani, N ^c   Ciusani, E ^b   Parati, E ^b   Alessandri, G ^b   Pessina, A ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

Author keywords

drug uptake; fat derived MSCs; Mesenchymal Stromal Cells; Taxol

Indexed keywords

ANTINEOPLASTIC AGENT; PACLITAXEL;

ADIPOSE TISSUE; ARTICLE; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECT; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; TUMOR CELL LINE;

ADIPOSE TISSUE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; MESENCHYMAL STROMAL CELLS; PACLITAXEL;

EID: 84886731750     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/03946320130260S105     Document Type: Article

References (27)

1. Weldon JE, Xiang L, Chertov O, Margulies I, Kreitman RJ, FitzGerald DJ, Pastan I,. A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity. Blood 2009; 113: 3792-3800.
2. Dhar S, Gu FX, Langer R, Farokhzad OC, Lippard SJ,. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt (IV) prodrug-PLGA-PEG nanoparticles. Proc Natl Acad Sci USA 2008; 105: 17356-17361.
3. Kucerova L, Altanerova V, Matuskova M, Tyciakova S, Altaner C,. Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res 2007; 67: 6304-6313.
4. Shah K,. Mesenchymal stem cells engineered for cancer therapy. Adv Drug Deliv Rev 2012; 64: 739-748.
5. Pessina A, Bonomi A, Coccè V, Invernici G, Navone S, Cavicchini L, Sisto F, Ferrari M, Viganò L, Locatelli A, Ciusani E, Cappelletti G, Cartelli D, Arnaldo C, Parati E, Marfia G, Pallini R, Falchetti ML, Alessandri G,. Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy. PLoS One. 2011; 6: e28321.
6. Pessina A, Coccè V, Bonomi A, Cavicchini L, Sisto F, Ferrari M, Ciusani E, Navone S, Marfia G, Parati E, Alessandri G,. Human Skin-Derived Fibroblasts Acquire In Vitro Anti-Tumor Potential After Priming with Paclitaxel. Anticancer Agents Med Chem. 2012 Aug 24. [Epub ahead of print]
7. Pessina A, Coccè V, Pascucci L, Bonomi A, Cavicchini L, Sisto F, Ferrari M, Ciusani E, Crovace A, Falchetti ML, Zicari S, Caruso A, Navone S, Marfia G, Benetti A, Ceccarelli P, Parati E, Alessandri G,. Mesenchymal stromal cells primed with Paclitaxel attract and kill leukaemia cells, inhibit angiogenesis and improve survival of leukaemia-bearing mice. Br J Haematol 2013 Jan 7. [Epub ahead of print]
8. Schiff PB, Fant J, Horwitz SB,. Promotion of microtubule assembly in vitro by taxol. Nature 1979; 277: 665-667.
9. Belotti D, Vergani V, Drudis T, Borsotti P, Pitelli MR, Viale G, Giavazzi R, Taraboletti G,. The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clin Cancer Res 1996; 2: 1843-1849.
10. Gimble JM, Guilak F, Bunnell BA,. Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells. Stem Cell Res Ther 2010; 1: 19-27.
11. Kern S, Eichler H, Stoeve J, Klüter H, Bieback K,. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006; 24: 1294-301.
12. Minowada J, Onuma T, Moore GE,. Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. J Natl Cancer Inst 1972; 49: 891-5.
13. Bloom ET,. Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture. Cancer Res 1972; 32: 960-967.
14. Mickey DD, Stone KR, Wunderli H, Mickey GH, Vollmer RT, Paulson DF,. Heterotransplantation of a human prostatic adenocarcinoma cell line in nude mice. Cancer Res 1977; 3711: 4049-58.
15. Longo L, Christiansen H, Christiansen NM, Cornaglia-Ferraris P, Lampert F,. N-myc amplification at chromosome band 1p32 in neuroblastoma cells as investigated by in situ hybridization. J Cancer Res Clin Oncol 1988; 114: 636-40.
16. Ross RA, Spengler BA, Biedler JL,. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J Natl Cancer Inst 1983; 71: 741-7.
17. Pessina A, Eletti B, Croera C, Savalli N, Diodovich C, Gribaldo L,. Pancreas developing markers expressed on human mononucleated umbilical cord blood cells. Biochem Biophys Res Commun. 2004; 323: 315-22.
18. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR,. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-7.
19. Wrasidlo W, Gaedicke G, Guy RK, Renaud J, Pitsinos E, Nicolaou KC, Reisfeld RA, Lode HN,. A novel 2′-(N-methylpyridinium acetate) prodrug of paclitaxel induces superior antitumor responses in preclinical cancer models. Bioconjug Chem. 2002; 13: 1093-9.
20. Reed LJ, Muench H,. A simple method of estimating fifty percent endpoints. Am J Hyg 1938; 27: 493-497.
21. Chaudhary PM, Roninson IB,. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J Natl Cancer Ins 1993; 85: 632-639.
22. Miranville A, Heeschen C, Sengenes C, Curat CA, Busse R, Bouloumie A,. Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation 2004; 110: 349-355.
23. Mizuno H, Tobita M, Uysal AC,. Concise Review: Adipose-Derived Stem Cells as a Novel Tool for Future Regenerative Medicine. Stem Cells 2012; 30: 804-810.
24. Vilalta M, Dégano IR, Bagó J, Gould D, Santos M, García-Arranz M, Ayats R, Fuster C, Chernajovsky Y, García-Olmo D, Rubio N, Blanco J,. Biodistribution, long-term survival, and safety of human adipose tissue-derived mesenchymal stem cells transplanted in nude mice by high sensitivity non-invasive bioluminescence imaging. Stem Cells Dev 2008; 17: 993-1003.
25. Ra JC, Shin IS, Kim SH, Kang SK, Kang BC, Lee HY, Kim YJ, Jo JY, Yoon EJ, Choi HJ, Kwon E,. Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev 2011; 20: 1297-308.
26. Tobita M, Orbay H, Mizuno H,. Adipose-derived stem cells: Current findings and future perspectives. Discov Med 2011; 11: 160-70.
27. Mariani E, Facchini A,. Clinical applications and biosafety of human adult mesenchymal stem cells. Curr Pharm Des 2012; 18: 1821-45.